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Summary.-(BALB/c x C57BL/6)F1 mice bearing an SV-40 fibrosarcoma in the limb
were injected with 0 045, 0-09 and 0.18 ,ug/g body wt actinomycin D into the tumour.
Similar animals were also treated with local hyperthermia (39.70, 42 3° and43-60C
intratumour temperature for 30 min). The marked increase in median survival time
following the combination ofdrug and local hyperthermiaindicates that the combined
treatment has a synergistic effect in the control ofsolid tumours. The median survival
time of animals receiving the two treatments in immediate succession was higher
than in animals with 30 min between treatments. This has important implications
for the therapy of human cancer.
THE inability to produce satisfactory
results using single therapeutic agents in
patients with advanced cancer led to their
use in combinations (De Vita and Schein,
1973). Complete remissions are rare with
single agents used against solid tumours,
and even when complete remissions are
achieved with single agents, their duration
is generally short (De Vita, Young and
Canellos, 1975).
Excessive toxicity of actinomycins,
including actinomycin D (ActD), is the
limiting factor in the use of these anti-
biotics in cancer chemotherapy. ActD is
active in the reduction of trophoblastic
tumours (Hertz, Ross and Lipsett, 1964),
germinal cell neoplasms (Li et al., 1960),
soft-tissue sarcomas (Einhorn, 1976) and
Wilms' tumour, and as an adjuvant to
radiotherapy (Wolf et al., 1968). However,
ActD is cytotoxic at an in vivo concentra-
tion of LD10 (0.6 pLg/g i.p.) in mice
(Morasca et al., 1974). It was found that, in
vitro, non-toxic concentrations of ActD
enhanced radiation damage by 10-200%
(Elkind et al., 1967). A critical limitation
of chemotherapy is the fact that a high
toxic drug concentration mustreachpoorly
vascularized areas of the tumour in order
to produce a beneficial therapeutic effect.
In order to circumvent the cytotoxic
effects of single-drug therapy, combina-
tions of several agents have been tried.
Most of the combinations were based on
the differential toxicities of the drugs
given separately.
Hyperthermia is more deleterious to
malignant than to normal tissue (Kim,
Kim and Hann, 1974; Muckle and
Dickson, 1971; Dickson and Suzangar,
1976). Hyperthermal enhancement of the
sensitivity of cancer cells to ionizing
radiation has been demonstrated in
humans (Selawry, Carlson and Moor,
1958; Cocket et al., 1967; Shoulders et al.,
1942; Warren, 1935; Brenner and
Yerushalmi, 1975), in experimental im-
planted tumours (Robinson, Wizenberg
and McCready, 1974; Crile, 1963; Hahn,
Alfieri and Kim, 1974; Yerushalmi, 1975,
1976a) and in cells in culture (Chen and
Heidelberger, 1969; Ben-Hur, Elkind and
Bronk, 1974). Hyperthermia has also been
shown to act as a sensitizer with cytotoxic
drugs (Dickson and Suzangar, 1974). Most
reports dealing with the combination of
elevated temperature and chemothera-
peutic drugs were connected with theA. YERUSHALMI
investigation of tumour cell-lines in vitro
(i.e., disconnected from the host). In order
to achieve conditions as close as possible
to the in vivo situation, I selected a solid
tumour, the SV-40 fibrosarcoma, and
treated it locally in the host. I present
results relative to the sensitizing effects of
hyperthermia and single, low, non-toxic
concentrations of ActD. Hyperthermia
potentiated ActD in (BALB/c x C57BL/
6)F1 mice bearing the SV-40-induced
fibrosarcoma, and the synergistic effect of
hyperthermia andActD wasdemonstrated.
The criterion of survival prolongation
was chosen to assess results, since it is
clinically the most significant, taking into
account all the treatment effects. This is,
of course, the actual goal of every experi-
mental and clinical trial inhuman patients.
MATERIALS AND) METHOD)S
(BALB/c x C57BL/6)F1 hybrid mice were
used throughout the experiments. The tumour
was an SV-40 fibrosarcoma maintained by
repeated passage. The tumour is positively
detected 5-7 days after transplantation, and
causes death within 30-40 days in untreated
animals. Spontaneous cures and metastases
were not seen during the experimental period
in untreated animals. The details of the
preparation of tumour and cell suspensions
have been described elsewhere (Yerushalmi,
1975). 106 viable tumour cells in 0 5 ml were
injected i.m. into the left hind leg. Ten to 11
days after transplantation, animals with
tumours of the same volume (1000-1100
mm3) wAeremixedtogether, randomlyselected,
and separated into the various treatment
groups. All animals were anaesthetized with
an i.p. injection of Pentobarbital Sodium.
Blood supply to the limb w%as not impaired
during treatment.
Heating system. The heating system has
been described in detail elsewhere (Yeru-
shalmi, 1976a). In short, it consisted of a
hot-air blower, a heat-insulated cylinder and a
temperature-control unit. For local heating,
the tumour bearing limbs of 4 mice at a time
were inserted into 4 holes drilled in the upper
part ofthe cylinder.
Temperature mneasurements.-The hot-air
atmosphere wNas achieved by passing hot air
through an attenuator to reduce turbulence.
Homogeneity was achieved, and confirmed by
a system ofvalvesandthermocouples installed
for temperature stability and control. Simul-
taneoustemperature measurements weremade
in the cylinder, in the tumour (to record intra-
tumour temperature) and in the ear of the
mouse (to record skin temperature). Prelimin-
ary experiments showed that intra-ear tem-
perature measurements were reliable indica-
tors of skin temperature (Benzinger and
Taylor, 1963; Yerusbalmi, 1976b). Measure-
ments wvere taken by copper constantan
thermocouples (1 0 mm thick) connected to an
electronic control unit which included a
continuous digital temperature read-out and
an X-Y recorder (Yerushalmi, 1976a, b).
Intratumour and body-temperature pro-
files are given elsewhere (Yerushalmi, 1976a).
Local heating of the tumour-bearing leg with
45°C hot air for 30 min produced an intra-
tumour temperature of 39 7±0 2°C. Local
heating at 50°C for 30 min produced a 42-3±
0 2°C intratumour temperature. Local heating
at 55°C hot air for 30 min raised intratumour
temperature to 43 6±0 2°C. Local heat
treatment at the highest heating temperature,
namely 55°C hot air raised the animal's body
temperature to 37 8°C, but this was well
tolerated by the treated animals. Heating
time includes heat build-up in the tumour
(-12 min).
ActDused wasAMD-CosmogenfromMerck,
Sharp and Dohme. The drug was dissolved
in sterile water and diluted to the treatment
concentrations. In all the experiments, the
drug was injected into the tumour. The 3
concentrations used were 0 045, 0 09 and 0-18
Hug/g body wt. The lowest value of0 045,g/g
was chosen because combined in vivo radio-
therapy and chemotherapy schedules of
0 05 jug/g had been used previouslv (Toma-
shefsky et al., 1976). ActD at 0-5 tug/g inhibits
the formation of ribosomal subunits in rat
liver (Woodscock and Mansbridge, 1971)
and the LD50 after i.p. injection was found
to be 0-59+0-17 tug/g (Rahman et al., 1974).
The median survival time (MST) was
calculated by the equationMST=L+(cj/fm),
where L is the lower day boundary of the
group containing the median animal, j is the
number ofdeaths needed to reach the median
animal in the median group, fm is the number
of deaths in the median group, and c is the
group interval (= 1 in these experiments)
(Miller, 1973).
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RESULTS
Drug cytotoxiocity was tested at the 3
concentrations used. Healthy control ani-
mals were injected i.p. and into the left
hind leg. No cytotoxic effects were
observed at these concentrations. In
normal and tumour-bearing, locally heated
animals, no leg losses and no deaths were
caused by the heat treatment. There was
no skin injury, except for slight hair
discoloration. The MST of every group
treated by the combined drug plus heat
treatment is compared to its untreated
control and drug only groups.
The effects of varying drug doses,
degrees of tumour hyperthermia, and the
combinations at varying intervals on
survival of tumour-bearing animals are
presented in Tables I and II.
The values in Table III show that, in
general, for each of the 3 drug doses
TABLE I. Median Survival Time (MST)
ofTumour-bearing Animals Treated with
ActD and ActD+Local Hyperthermia
(in Parentheses, No. of Animals in
Group)
Untreated controls
0 -045 /tg/g
0 -09 Hg/g
0 18 Htg/g
Untreated controls
0 045 ttglg
0 09 pg/g
0 18 Htg/g
Untreated controls
0 045 Htg/g
0 09 iLg/g
0 18 tcg/g
Untreated controls
0 045 ,g/g
0 -09 pg/g
0 - 18 Htg/g
ActD
only
40 (10)
44 (12)
43 (13)
41 (10)
39 (9)
41 (10)
42 (10)
47 (11)
39 (9)
43 (10)
44 (10)
43 (10)
40 (10)
42 (9)
44 (10)
46 (10)
ActD+
local heat
(a)
ActD
twice
(b)
39 (13)
42 (14)
46 (16)
44 (12)
39 7 C
41 (10)
44 (10)
43 (10)
42 3°C
47 (11)
44 (12)
48 (10)
43 6°C
61 (12)
89 (10)*
54 (11)
(a) Schedule: injection of ActD, followed at once
by local hyperthermia at the indicated tumour
temperature.
(b) 2 injections at an interval of 2 days.
(*) 2 animals cutred 275 days after treatment.
TABLE II.-Median Survival Time (MST)
ofTumour-bearing Animals Treated with
ActD and with ActD+Local Hyper-
thermia (in Parentheses, No. of Animals
in Group)
Dose of
ActD Schedlule (a)
0 045 jug/g
0 045 ,tg/g H, 0, I
0 045 ,tg/g H, 30, I
0 045 ,tg/g I, 30, H
0 09,ug/g 1H,0,I
0 09 ,ug/g H, 30, 1
Intra-
tumour
temp.
42 - 3°C
41 (9)
48 (8)
45 (8)
41 (8)
55 (8)*
49 (8)
Intra-
tumour
temp.
43 C 6°C
42 5 (9)
51 (9)
No
heat
41 (18)
44 (9)
40 (9)
65 (7)1:
(a) H (heat) oIr I (injection) with interval in
minutes.
(*) One animal cured, 195 days after treatment.
(1) One animal cured, 210 days after treatment.
TABLE III.- Temperature-dependent In-
crease in EMSTR When Heat Immediate-
ly Follows Drug
EMSTR -
MST of drug+heat-treated animals
MST ofdrug-treated animals
Drug dose
(jtglg)
0 045
0-09
0 18
Intratumour temperature, °C
:39-7 42-3 43-6
1 1-09 1-45
1-05 1 2-02
0-92 1-12 1-17
tested, there is a temperature-dependent
increase in the EMSTR (Enhancement of
MST ratio).
DISCUSSION
The curative limits of single-drug
chemotherapy are well known. Moreover,
the side effects of most cancer chemo-
therapy drugs appear to be dose-depen-
dent. ActD toxicity was found to be
cumulative over a wide range of dose
schedules in mice and rats (Goldin and
Johnson, 1974). Therefore, any possible
method which allows the reduction of
total drug dose and its toxicity, while
achieving the same tumour-cell kill, is
clinically relevant. The toxic, hyper-
thermic, and the combined heat+drug
effects on tumour-bearing animals cannot
be evaluated in an in vitro system.
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In vitro studies have shown that raised
temperatures resulted in immediate but
reversible increased diffusion of low-mol.-
wt compounds through the cell membrane
(Storm et al., 1975) and the synergism of
antibiotics with hyperthermia was demon-
strated (Mondovi et al., 1969a, b). More-
over, small differences in the conditions of
in vitro experiments demonstrated results
due to factors other than the heating
effects (Mondovi et al., 1969a).
It is known that cells from the same
tumour behave differently in vitro and in
vivo. Inthe tumour invivoanon-proliferat-
ing fraction is a part ofthe cell population.
Therefore, in vitro partial cell kill, due to
hyperthermia or hyperthermia combined
with drugs, may indicate only the response
ofthe fast-proliferating cell fraction ofthe
tumour, which is dependent on heating
time. However, cells that are not fully
destroyed by heat recover. This important
cell fraction exists in the tumour in vivo,
and the success or failure in destroying
these cells can be monitored only in vivo,
by the observation oftumour growth.
Furthermore, alterations in respiration
and glycolysis, inhibition of DNA, RNA,
and protein synthesis in vitro, due to heat,
could be only a partial cause of the
destruction of tumour cells. Thus, extra-
polation to the in vivo reality is irrelevant,
because of the host-tumour relationships
missing from the in vitro situation. It
should be emphasized that there is no
information comparing the in vitro hyper-
thermic response of human tumours with
the response of the same tumours in the
patient.
Therefore, the importance of in vitro-
in vivo studies in heat damage to tumour
growth was emphasized (Dickson and
Suzangar, 1974).
The local treatment of a solid tumour,
by injecting the drug into the tumour, and
local heating of the tumour, has the
advantage of taking into account all the
above-mentioned effects in the host, while
treating a defined mass of tumour cells.
The purpose ofthe present investigation
was to examine the synergism of local
hyperthermia and ActD in the control of
local tumour growth, and thus reduce the
concentration ofActD. Drug administered
immediately before or after local hyper-
thermia increased tumour-control, demon-
strating the synergism of local hyper-
thermia and ActD. In general, drug
injected 30 min before or after heating
resulted in less tumour control than the
immediate combinations of injection and
heating, in either order. In parallel experi-
ments (unpublished) the drug was allowed
to stay at 37°C for 2 h, injected and
immediately heated or heated and im-
mediately injected, with the same results
as in Tables 1-111. Therefore, artefacts due
to changes in drug activity can be ruled
out, and the increased tumour control in
the immediate combinations oftreatments
may be attributed to the combined effect
of heat + drug. Again, it should be borne
in mind that all the treatments consisted of
a single low dose of ActD combined with
local heating. Therefore, the failure to
increase the cure rate does not rule out the
possible usefulness of this method.
In the present investigation, I showed
that a single, low, nontoxic dose of ActD,
combined with local tumour heating,
provides a more effective control of local
tumour growth than either agent used
singly, and that local heating enhances the
action ofActD in tumourcontrol, probably
by allowing a higher concentration of the
drug to reach the hypoxic tumour cells.
Low concentrations of AMD in poorly
vascularized hypoxic sites may therefore
be clinically effective when combined with
heat. A single treatment of the combined
heat + chemotherapy markedlyprolonged
the MST and even produced some cures,
when compared to ActD-treated animals.
The most significant results were obtained
with the 43 60C localintratumourtempera-
ture combined with the 0 09 jug/g drug
treatment, and there was a temperature-
dependent increase in EMSTR at each of
the 3 drug doses tested.
The marked increase in life span after
the combined drug + local hyperthermia
therapy indicates that the method may be
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useful in solid tumour therapy. Further-
more, data on optimal drug dose, heating
temperature and duration oflocal heating,
are critical in the design ofthis treatment
regimen, and investigations similar to
these, with the combination of simultane-
ous heat and ionizing radiation
(Yerushalmi, 1976a) should be performed.
The author wishes to thank Dr G. Yagil for helpful
suggestions during the preparation of this manu-
script.
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